Tag: target

The Miracle of Regenerative Medicine

Filed in AMAG, BP, Gold, Gold Market, HAL, o, target by on February 17, 2011 0 Comments
The Miracle of Regenerative Medicine

Tall, dark, and handsome… Dr. Anthony Atala is not a guy you could easily mistake for Dr. Frankenstein. Yet, in his white lab coat, Atala is doing exactly what author Mary Shelley wrote about so long ago. A mad scientist in his own right, he is busy growing body parts in his Wake Forest lab. A finger here, a bladder there, Atala is currently growing dozens of different tissues. And from heart valves to muscles to ears, his Institute for Regenerative Medicine is literally about to turn the world on its head. Working at one of the world’s largest research facilities dedicated to regenerative medicine, the modern Dr. Frankenstein is adamant that his research will one day replace diseased or damaged tissue using homegrown replacement parts. After all, as Dr. Atala often pondered, “A salamander can grow back its leg, why can’t a human do the same?” Now, some twenty-four years later, that notion is no longer just a wild hypothetical; it’s a feat of modern science, stripped from the pages of a 194-year-old novel. Today, regenerative medicine stocks are the companies to watch as this amazing new technology unfolds. The promise of regenerative medicine Take the story of Claudia Castillo, for instance. In 2008, this 30-year-old mother of two became the first patient to receive a whole organ transplant without the need for powerful anti-rejection drugs. Damaged by a bout of tuberculosis, her entire windpipe was repaired with a replacement part created with the help of her own stem cells. And given the choice between losing a lung or becoming a guinea pig for a radical new medical technique, Castillo chose the latter— becoming one of the pioneers for future regenerative surgeries. Her life these days is not only back to normal… She recently called her doctors from a nightclub to tell them she had been out dancing all night. Before the ground-breaking surgery, Castillo could barely climb the stairs. Claudia’s story is just the beginning… In fact Dr. Atala’s team is currently working on re-growing over 23 different organs including the liver, heart, kidney, and bladder. Along the way, they have conquered a number of milestones in the field. From the website , these firsts include: Developing biological strategies to enable certain human cell types that were previously thought not to be expandable outside the body to be grown in…

Continue Reading »

Inflation in (Mostly) the Wrong Places

It is often claimed that inflation is a benign, even positive, force. People assume that prices, wages, and assets will all rise together… In the real world, inflationary episodes don’t play out that way. Wages don’t keep up, and bubbles form in unexpected (and unwanted) places. In America, compensation is clearly stagnant. And the outlook for future pay raises is not good, as this chart from David Rosenberg shows: Contrast that with this next chart, which shows the percentage of companies planning to raise prices: Combine stagnant wages and slow growth with high unemployment and rising prices, and you get a recipe for stagflation. This scenario is being played out around the world. In the UK, consumer prices rose 4% in 2010. As noted by the Financial Times , wages aren’t keeping up: The prices of everyday goods and services are rising about twice as rapidly as average wages, Tuesday’s inflation figures confirmed — which means that the standard of living of many Britons is already falling. According to the Bank of England, average pay at the end of this year will be able to buy no more than it could in 2005. It is the first time that the purchasing power of earnings has fallen so far since the 1920s. I expect this trend to continue as long as the Fed’s mad experiment is ongoing. The thing about Central Bank “easing” is you never know where inflation will pop up… Easy money will always fuel speculators, who have little skin in the game, to find another bubble to “invest” in. Silver, gold, oil With printing presses switched “on” for the foreseeable future, we remain bullish on precious metals. Silver is holding above $30 today and could hit $37.50 on the next leg up. Coal, oil, and natural gas investments should continue to do well. And as my colleague Nick Hodge of Energy and Capital says, “Buy it if it burns.” If you’re not yet convinced that Fed printing is directly related to rising commodity prices, examine the following chart. (The solid blue line represents the Austrian Money Supply (AMS), and the solid teal line represents commodity prices ( IMF Commodity Index )): Note: The version of money supply shown

Continue Reading »

Marathon Oil’s Target Boosted at Goldman Sachs (MRO)

Integrated oil and natural gas producer Marathon Oil Corporation ( MRO ) on Monday saw its price target upped by analysts at Goldman Sachs. The firm said it raised its target on MRO from $51 to $58, which implies a 27% upside to the stock’s Friday closing price of $46.48. Goldman also reiterated its “Buy” rating on the stock, saying that “Based on our updated E&P valuation analysis, we continue to see Marathon as an inexpensive means to gain exposure to our constructive outlook for Mid-Continent refining margins.” Marathon Oil shares were mostly flat in premarket trading Monday. The Bottom Line We have been recommending shares of Marathon Oil ( MRO ) since Jan.26, 2011, when the stock was trading at $43.55. The company has a 2.15% dividend yield, based on Friday’s closing stock price of $ 46.48. Marathon Oil Corporation ( MRO ) is a “Recommended” dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »

Weekend: The Fool Proof Retirement Plan

Welcome to the Wealth Daily Weekend Edition— our insights from the week in investing and links to our most-read Wealth Daily and sister publication articles. As I wrote earlier in the week, dividend reinvestment plans — or DRIPs — are a great way to secure your financial future. All you need is the time and patience to stick to the blueprint… The best part is these plans are offered by more than 1,100 companies and are available to investors of all stripes, making it possible to purchase shares of stock without using a broker. This allows investors to buy stock directly from the company in very small amounts— something that can be more difficult and costly when compared to buying shares through your broker. In fact most companies don’t charge a fee, and the minimum investment can be as low as $10. Advertisement 60 Minutes Reports on Growing Body Parts Call it what you want: biotechnology, tissue engineering, cell therapy, regenerative medicine. The famous newsmagazine has reported on one doctor about to make multiple medical problems disappear forever. Lucky for you, that same doctor sits on the board of a $3.00 company that will bring these solutions to market— making shareholders rich in the process. Check out the 60 Minutes clip to learn the name. The plans also reinvest all or partial dividends paid into more stock, thus the name “Dividend Reinvestment Plan.” And in this case — since the investment is based on dollar amounts — you can purchase fractional shares. In addition, investors can choose to add a monthly contribution to the plan, boosting the amount of wealth the DRIP can create. That means you can start out with as little…

Continue Reading »

All That Jazz (JAZZ): Biotech Targets Narcolepsy, OCD and Anxiety

Filed in Bank Gold, EPS, o, revenue, target by on February 8, 2011 0 Comments
All That Jazz (JAZZ): Biotech Targets Narcolepsy, OCD and Anxiety

Filed under: Newsletters , Stocks to Buy “The visible growth story at Jazz Pharmaceuticals ( JAZZ ) is the narcolepsy treatment Xyrem, which accounts for 85% of revenues,” says growth stock specialist Mike Cintolo . The editor of Cabot Top Ten Weekly Report explains, “But Jazz has great potential to make big money with other drugs too-all of which focus on the chemistry of the brain. “Thanks to patents, Jazz has a decade to run with Xyrem before generic competitors can enter the market. Meanwhile, its drugs have potential to treat and/or cure obsessive-compulsive disorders, anxiety disorders, fibromyalgia, epilepsy and restless leg syndrome. Continue reading All That Jazz (JAZZ): Biotech Targets Narcolepsy, OCD and Anxiety All That Jazz (JAZZ): Biotech Targets Narcolepsy, OCD and Anxiety originally appeared on BloggingStocks on Tue, 08 Feb 2011 11:00:00 EST. Please see our terms for use of feeds . Permalink | Email this | Comments

Continue Reading »

An Egyptian Firebrand Away from $400 Oil

Investors are remarkably sanguine about the events in Tunisia and Egypt… Oil actually fell yesterday to $88.27. The Dow has been on a hot streak and is up again today — as it has been for months — to 12,149. History suggests events in the Middle East go from bad to worse. According to the Democracy Index put out by The Economist , there are no “established democracies” in the region. Israel is listed as a “flawed democracy.” Lebanon and Turkey were listed as “hybrid regime,” along with Palestinian territories, Pakistan, Armenia, and Iraq (Lebanon is now run by Hezbollah). The rest are categorized as “authoritarian regimes.” The last free vote saw Hamas sweep the Palestinian elections in 2006. Hamas started as an offshoot of the Muslim Brotherhood in Egypt. On gaining power, they started lobbing rockets into Israel. In 2007, the Battle of Gaza was fought between Hamas and the Palestinian security forces. Hamas is listed as a terrorist organization in most G-20 countries. In the aftermath, Israel and a Hosni Mubarak-ruled Egypt imposed an economic blockade on Gaza that is still in effect. Population and scarcity Jack Andrew Goldstone points out in his book, Revolution and Rebellion in the Early Modern World , that all revolutions from the French to the Russian, from China to Japan, occur where there is a rising population and diminishing resources coupled with an inflexible ruling party. (Note: The population in Russian doubled between 1850 and 1913.) Today, the Arab world has the fastest growing population on earth— and the youngest. In Yemen, the average age is 17.9 years with a birth replacement rate of 2.71, which puts it at number 23 in the world. The United Arab Emirates is in fourth place with 3.56, Kuwait is fifth with 3.50, the Gaza strip is six with 3.29. Libya, Chad, Egypt, Oman, Syria, and Iraq all make the top quintile. These young people will be the next rulers of the largest oil-producing region within the next ten years — mostly because all of the current leaders are in their 80s… with the exception of Qaddafi…

Continue Reading »

Darden Restaurants’ Target, Estimates Boosted at Susquehanna (DRI)

Full-service restaurant operator Darden Restaurants, Inc. ( DRI ) on Friday saw its price target and earnings estimates raised by analysts at Susquehanna. The firm said it lifted its price target on DRI from $56 to $57, which implies a 16% upside to the stock’s Thursday closing price of $49.30. Susquehanna also maintained its “Positive” rating on DRI, and boosted its earnings estimates. The analyst said that “expectations for 7-8% commodity inflation over the next 18 months will be a headwind to margin expansion; however, we view DRI as best able to defend margins with price increases, supply chain efficiencies, and real estate ownership.” Darden Restaurants shares were mostly flat in premarket trading Friday. The Bottom Line Shares of Darden Restaurants ( DRI ) have a 2.60% dividend yield, based on last night’s closing stock price of $49.30. The stock has technical support in the $44-$46 price area. The shares are trading near all-time highs and have little overhead resistance. Darden Restaurants, Inc. ( DRI ) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »

Kellogg Upgraded to “Outperform” at Wells Fargo (K)

Cereal maker Kellogg Company ( K ) on Friday saw its rating and price target boosted on Friday by analysts at Wells Fargo. The firm said it upgraded K from “Market Perform” to “Outperform,” while boosting its valuation range from $51-$53 to $58-$60. That new target implies up to a 14% upside to the stock’s Thursday closing price of $52.52. A Wells analyst commented, “We expect Kellogg’s shares to appreciate as earnings surprise to the upside driven by a faster-than-expected recovery in its core N.A. retail cereal business. Kellogg enters 2011 with a 25% increase in new products versus 2009-2010 levels, increased investment in its supply chain, easy comparisons and list price increases already implemented to help cover surging input costs…our 2011E EPS to $3.50 from $3.40 (versus $3.46 consensus) and our 2012 estimate from $3.75 to $3.85 (versus $3.79 consensus) as a result.” Kellogg shares posted modest gains in premarket trading Friday. The Bottom Line We have been recommending shares of Kellogg ( K ) since Nov.3, 2010, when the stock was trading at $49.69. The company has a 3.08% dividend yield, based on last night’s closing stock price of $52.52. Kellogg Company ( K ) is a “Recommended” dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »

General Electric’s Price Target Boosted at Oppenheimer (GE)

Multinational conglomerate General Electric Company ( GE ) on Wednesday saw its price target boosted by analysts at Oppenheimer. The firm said it now expects GE shares to reach $25, which implies a more than 20% upside to the stock’s Tuesday closing price of $20.80. Oppenheimer also maintained its “Outperform” rating on GE, citing strong growth in its industrial segment. General Electric shares were mostly flat in premarket trading Wednesday. The Bottom Line We have been recommending shares of General Electric ( GE ) since July 23, 2010, when the stock was trading at $15.21. The company has a 2.69% dividend yield, based on last night’s closing stock price of $20.80. General Electric Company ( GE ) is a “Recommended” dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »

Buying Blood in the Streets: A How-To Guide

Filed in BP, Gold, Gold Market, o, target by on January 31, 2011 0 Comments
Buying Blood in the Streets: A How-To Guide

There’s no cash in the ATMs, there’s something like 5,000 prisoners roaming the streets and there’s no security. — May Sadek, man on the street, Cairo In my financial trading service Crisis & Opportunity , I seek maximum returns by buying stocks when fear is the highest, and selling them when the panic dissipates. It might sound crude and insensitive to buy stocks in places where people are literally dying, but it works; and by supporting the stock market when everyone is fleeing, you are reducing the panic— which is a positive for financial stability. Baron Von Rothschild is credited with saying, “The time to buy is when blood is running in the streets.” He’s been re-quoted by everyone from Mobius to Rockefeller. But through extensive research, I uncovered this bit from The New York Times circa 1931… It has been reported during the aftermath of the Franco-Prussian War, when the French had been defeated and the mob was looting Paris, a friend of his asked, “What are you going to do to protect your interests in this dreadful hour?” The Baron said to him, “Can you keep a secret?” He replied, “Yes.” The Baron said, “Well, if the truth must be told, I am protecting myself by buying real estate.” His friend responded, “Do you mean to say you are buying real estate with the gutters of Paris running with blood and the city in the hands of a mob?” Rothschild said, “Yes, my friend, I mean that very thing, and that is the only time, when the gutters are running with blood, that you can buy real estate at 50 cents on the dollar.” Istanbul to Constantinople Buying blood in the streets has become a hoary Wall Street platitude because it is extremely profitable. The thing about revolutions is that the countries don’t disappear… Sure, governments come and go, the names and lines on maps change and are redrawn— but the people and resources remain. I can name a number of countries off the top of my head that had post-revolution stock market booms: South Korea, Indonesia, Malaysia, Sri Lanka, Russia, South Africa… the list goes on. When you invest in foreign markets that are in crisis, you get a bounce-back on both the equity side and the currency side. Here is an example: In 1998, the people of Indonesia took to the streets and threw off long-term dictator Suharto. The market crashed, and the currency went from 350 to the dollar to over 15,000 before it stopped trading altogether. One of the Indonesian blue chips— P.T. Telecom — fell from the low $30s to $1.50. The currency now trades at 9,047 rupiah to the dollar. If you put $10,000 in TLK at $1.50 and held it to the top, you would have made $366,000 on the share price— plus another 30% or so on the currency…

Continue Reading »

PPG’s Estimates Boosted at Goldman Sachs (PPG)

Paint and coatings maker PPG Industries, Inc. ( PPG ) on Monday saw its earnings estimates raised by analysts at Goldman Sachs. The firm said it boosted its estimates for PPG through 2012, noting that recent acquisitions should bolster its earnings. Goldman also cited share buybacks as another positive catalyst for the company. The analyst maintained its “Buy” rating and $104 price target, which implies a 25% upside to PPG’s Friday closing price of $83.23. PPG Industries shares were mostly flat in premarket trading Monday. The Bottom Line We have been recommending shares of PPG Industries ( PPG ) since Oct.21, 2010, when the stock was trading at $77.46. The company has a 2.64% dividend yield, based on Friday’s closings stock price of $83.23. PPG Industries, Inc. ( PPG ) is a “Recommended” dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »

Kraft Foods’ Estimates Cut at Credit Suisse on Cost Concerns (KFT)

Filed in dividend, earnings, EPS, Gold Bullion prices, o, outperform, shares, target by on January 31, 2011 0 Comments

Packaged foods maker Kraft Foods Inc. ( KFT ) on Monday saw its earnings estimates lowered through 2012 by analysts at Credit Suisse. The firm said it cut its 2011 and 2012 EPS estimates for KFT to $2.23 and $2.45, respectively. Credit Suisse cited rising costs for the move, as many food sellers have been feeling the crunch. Still, the analyst maintained its “Outperform” rating and $35 price target on KFT, which implies a 15% upside to the stock’s Friday closing price of $30.53. Kraft Foods shares were mostly flat in premarket trading Monday. The Bottom Line We have been recommending shares of Kraft Foods ( KFT ) since May 5, 2009, when the stock was trading at $24.26. The company has a 3.80% dividend yield, based on Friday’s closing stock price of $30.53. Kraft Foods Inc. ( KFT ) is a “Recommended” dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars. Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .

Continue Reading »